The Korea Disease Control and Prevention Agency, National Institute of Health in Korea from Asian region had released this tender for [General Service] (Negotiation) Immunogenicity evaluation and analysis of general-purpose Nipah virus vaccine candidates with tender notice no. R26BK01524285 published on 15 May 2026. The tender expired on 27 May 2026. This tender is sourced from G2b Korea and is eligible for suppliers interested in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, General anti-infectives for systemic use and vaccines, Antineoplastic and immunomodulating agents, Immune sera and immunoglobulins, Influenza vaccines. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 12860372.
*The deadline for this tender has passed.
Tender Notice No:
R26BK01524285
Tender Organisation:
Korea Disease Control and Prevention Agency, National Institute of Health
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33650000 : General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33651000 : General anti-infectives for systemic use and vaccines
33652000 : Antineoplastic and immunomodulating agents
33651500 : Immune sera and immunoglobulins
33651660 : Influenza vaccines
Tender Source:
G2b Korea
Tender Document Type:
Tender Notice
Tender Description:
[General Service] (Negotiation) Immunogenicity evaluation and analysis of general-purpose Nipah virus vaccine candidates
Tender Bidding Type:
Tender Document:
Looking for more tenders like this one in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, General anti-infectives for systemic use and vaccines, Antineoplastic and immunomodulating agents, Immune sera and immunoglobulins, Influenza vaccines? With over 11 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Defence sector in Korea, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Korea is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33650000, 33651000, 33652000, 33651500, 33651660, enabling precise filtering. Search by:
While you're viewing a tender in Korea, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Request a free live demo now to unlock tenders customized to your Defence, Korea, and General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, General anti-infectives for systemic use and vaccines, Antineoplastic and immunomodulating agents, Immune sera and immunoglobulins, Influenza vaccines categories.
The tender has been issued by Korea Disease Control and Prevention Agency, National Institute of Health in Korea. Such a type of tender falls under General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, General anti-infectives for systemic use and vaccines, Antineoplastic and immunomodulating agents, Immune sera and immunoglobulins, Influenza vaccines, within the Defence Tenders sector, and is listed on Tender Impulse under notice number R26BK01524285.
The notice was published on 15 May 2026 and submissions close on 27 May 2026. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
It is classified under CPV codes 33650000, 33651000, 33652000, 33651500, 33651660, which correspond to General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, General anti-infectives for systemic use and vaccines, Antineoplastic and immunomodulating agents, Immune sera and immunoglobulins, Influenza vaccines. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to Korea Disease Control and Prevention Agency, National Institute of Health, using the method described in the original tender document, before 27 May 2026. Tender Impulse provides complete assistance in submitting all bids posted on its website.
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to Korea Disease Control and Prevention Agency, National Institute of Health. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
There are currently 13846 live tenders of 1337487 total tenders from Korea on Tender Impulse. You can browse them on our Korea tenders page, or save a search combining Korea with CPV codes {full_cpv_codes} - we will then email you every new match on the day it is published.
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
The procurement is applicable to companies in the General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, General anti-infectives for systemic use and vaccines, Antineoplastic and immunomodulating agents, Immune sera and immunoglobulins, Influenza vaccines and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
The public procurement trends for General Service (Negotiation) Immunogenicity evaluation and analysis of general-purpose Nipah virus vaccine candidates can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Your action completed successfully.